|1.||Miwa, Koichi: 2 articles (06/2006 - 08/2004)|
|2.||Hattori, Takanori: 2 articles (06/2006 - 08/2004)|
|3.||Miyashita, Tomoharu: 2 articles (06/2006 - 08/2004)|
|4.||Aparecido Cordeiro, Fabio: 1 article (12/2010)|
|5.||Bertechini Faria, Carla: 1 article (12/2010)|
|6.||Parra Barbosa-Tessmann, Ione: 1 article (12/2010)|
|7.||Ruffin, Mack T: 1 article (01/2010)|
|8.||Normolle, Daniel P: 1 article (01/2010)|
|9.||Evelegh, Michael J: 1 article (01/2010)|
|10.||Baron, John A: 1 article (01/2010)|
06/15/2004 - "Prospective evaluation of a novel approach for the use of a quantitative galactose oxidase-Schiff reaction in ductal fluid samples from women with breast carcinoma."
01/01/1994 - "A sequential galactose oxidase technique (overnight incubation), followed by Schiff's reaction (15 minutes), was done on deparaffinized tissue sections of 65 carcinomas, 25 hyperplasias, 11 foci of adenosis, and 10 normal specimens. "
10/01/1988 - "The majority of the carcinoma cells gave histochemically positive reactions for galactose oxidase-Schiff, stable class III con A, and high-iron diamine-alcian blue (HID-AB). "
01/01/1997 - "Analysis of mucin histochemistry by staining with paradoxical concanavalin A (PCA) and galactose oxidase-Schiff (GOS), which are markers for expression of the gastric phenotype, revealed that these mucins were positive in submucosal adenocystic proliferation and carcinoma at the anastomotic site. "
01/01/1991 - "The results showed that the carcinoma contained mucins, which showed reactivities characteristic of the gastric surface mucous cell (galactose oxidase-cold thionin Schiff reactive) and gland mucous cell (paradoxical concanavalin A staining reactive). "
|2.||Stomach Neoplasms (Stomach Cancer)
09/01/1993 - "Surface mucous cell differentiation of gastric cancers of each histologic type has previously been detected by the galactose oxidase-Schiff (GOS) reaction although this is not always positive in all cases. "
09/01/1993 - "Galactose oxidase-Schiff, SH-9 and cathepsin E reactive or positive cancer cells were found in 145 (71.4%), 151 (74.4%) and 144 (70.9%), respectively, of the 203 primary stomach cancers investigated."
09/01/1993 - "Markers of surface mucous cell type human gastric cancer cells: galactose oxidase-Schiff reactive mucins, monoclonal antibody SH-9 reactive mucins and cathepsin E."
07/01/1990 - "Histochemical differentiation of mucins (paradoxical concanavalin A, the galactose oxidase-Schiff sequence and sialidase-galactose oxidase-Schiff) and immunohistochemical staining of Pgs I and II, allowed differentiation of gastric cancer cells from different histological categories into gastric elements including mucous neck cells, pyloric gland cells and surface mucous cells or intestinal elements including goblet cell and intestinal absorptive cell types. "
08/01/1990 - "By histochemical staining for mucin [by the paradoxical concanavalin A method, the modified method with labeled peanut lectin, the galactose oxidase-Schiff (GOS) reaction, and the sialidase-GOS reaction] and immunohistochemical staining of Pg 1, gastric cancer cells of each histological group could be clearly classified into a gastric type, including mucous neck cell pyloric gland cell, and surface mucous cell subtypes, and an intestinal type, including goblet-cell, and intestinal absorptive cell subtypes. "
|3.||Congenital Dyserythropoietic Anemia (Dyserythropoietic Anemia, Congenital)
08/01/1982 - "We report a study of HEMPAS erythrocyte membrane glycoproteins in relation to proteolytic digestion and surface labelling with galactose-oxidase/NaB[3H]4. The proteolytic digestion of band 3, the major intrinsic glycoprotein of the human erythrocyte membrane, reveals an abnormality in the outer glycosylated segment of this protein. "
01/01/1984 - "HEMPAS erythrocytes showed an abnormal glycoprotein profile when cells were labelled by the galactose oxidase/NaB[3H]4 method; Band 3 and Band 4.5 glycoproteins in HEMPAS are labelled but with less intensity although normally these proteins are the major components revealed by the same method. "
08/01/1982 - "3H incorporation in band 3 and band 4.5 glycoproteins after treatment with galactose-oxidase/NaB[3H]4 is reduced in HEMPAS red cells suggesting a defective glycosylation of these proteins. "
|4.||Graft vs Host Disease (Graft-Versus-Host Disease)
06/15/2004 - "The galactose oxidase-Schiff reaction (GOS) yields positive findings in a number of malignant solid tumors. "
02/01/2004 - "Galactose oxidase-Schiff (GOS) staining revealed that the cytoplasm of the normal surface epithelium and surface mucosubstances of the proventriculus adjacent to the neoplasm were positive in both cases. "
12/01/2010 - "Galactose oxidase (GO) converts galactose to an aldehyde and has several biotechnological applications, including cancer diagnosis. "
01/01/1984 - "Neuraminidase/galactose oxidase/NaB3H4-labeled NF skin and control skin cells possessed a 220 kD protein that was less intensively labeled in the tumor cells. "
07/01/1977 - "Increased binding and killing of neuraminidase-galactose oxidase-treated tumor cells by normal macrophages."
|6.||sodium borohydride (sodium tetrahydroborate)
|9.||Membrane Glycoproteins (Membrane Glycoprotein)
|10.||Proteins (Proteins, Gene)